# Tolerance of Targeted Therapy Used in Metastatic Melanoma in Patients Aged Over 65 and 75-year-old

> **NCT03155217** · — · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 358 (actual)

## Conditions studied

- Metastatic Melanoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03155217
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-05
- **Primary completion:** 2018-11-30
- **Final completion:** 2018-12-31
- **Target enrollment:** 358 (ACTUAL)
- **Last updated:** 2019-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03155217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03155217, "Tolerance of Targeted Therapy Used in Metastatic Melanoma in Patients Aged Over 65 and 75-year-old". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03155217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*